Market Opportunity DAT imaging and machine learning position LikeMinds at the intersection of diagnostics, early disease detection, and precision therapy for dopamine-related disorders, suggesting potential upsell opportunities with biotech firms and pharma companies seeking advanced imaging analytics and predictive biomarkers.

Strategic Partnerships A globally recognized board and strategic collaborators indicate openness to co-development and alliance deals; target potential collaboration with pharma and contract research organizations focused on neurology, movement disorders, and CNS biomarkers.

Revenue Levers Current revenue is within a modest SMB-to-mid-market range; explore tiered SaaS or data services offerings, expanding with additional modules for imaging analytics, ML model integration, and platform access for research and clinical trial teams.

Technology Stack Existing tech footprint includes standard enterprise tools and analytics platforms; opportunities exist to tailor enterprise-grade data integration, security, and compliance packages to larger customers or CROs seeking robust data pipelines.

Market Positioning Past partnerships in community and campaign projects demonstrate versatility beyond biotech imaging; leverage this narrative to approach crossover markets such as patient advocacy groups, academic consortia, and translational research networks for pilot studies and early-adopter programs.